Yahoo
Taipei Exchange - Delayed Quote TWD

Foresee Pharmaceuticals Co., Ltd. (6576.TWO)

75.00 -0.80 (-1.06%)
At close: October 30 at 1:30:37 PM GMT+8
View in AlphaSpace Currency in TWD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
471,126
431,274
418,689
195,038
301,506
Cost of Revenue
105,044
137,057
178,888
81,066
25,539
Gross Profit
366,082
294,217
239,801
113,972
275,967
Operating Expense
858,391
1,156,533
1,319,591
1,121,598
745,406
Operating Income
-492,309
-862,316
-1,079,790
-1,007,626
-469,439
Net Non Operating Interest Income Expense
7,738
12,607
21,573
20,676
7,934
Pretax Income
89,251
-858,203
-1,033,203
-988,635
-438,130
Tax Provision
66,755
24,948
47,869
47,667
34,508
Net Income Common Stockholders
22,496
-883,151
-1,081,072
-1,036,302
-472,638
Diluted NI Available to Com Stockholders
22,496
-883,151
-1,081,072
-1,036,302
-472,638
Basic EPS
0.12
-5.70
-7.87
-8.14
-4.00
Diluted EPS
0.12
-5.70
-7.87
-8.14
-4.00
Basic Average Shares
157,540.54
154,896
137,324
127,277
118,073.52
Diluted Average Shares
157,540.54
154,896
137,324
127,277
118,073.52
Total Expenses
963,435
1,293,590
1,498,479
1,202,664
770,945
Net Income from Continuing & Discontinued Operation
22,496
-883,151
-1,081,072
-1,036,302
-472,638
Normalized Income
22,496
-883,151
-1,081,072
-1,036,302
-472,638
Interest Income
16,142
18,174
28,281
23,525
8,336
Interest Expense
8,404
5,567
6,708
2,849
402
Net Interest Income
7,738
12,607
21,573
20,676
7,934
EBIT
97,655
-852,636
-1,026,495
-985,786
-437,728
EBITDA
153,834
-784,502
-945,975
-912,160
-386,576
Reconciled Cost of Revenue
105,044
137,057
178,888
81,066
25,539
Reconciled Depreciation
56,179
68,134
80,520
73,626
51,152
Net Income from Continuing Operation Net Minority Interest
22,496
-883,151
-1,081,072
-1,036,302
-472,638
Normalized EBITDA
153,834
-784,502
-945,975
-912,160
-386,576
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 4/12/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: